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Abstract: We develop and validate a Modified Beer-Lambert law for blood
flow based on diffuse correlation spectroscopy (DCS) measurements. The
new formulation enables blood flow monitoring from temporal intensity
autocorrelation function data taken at single or multiple delay-times.
Consequentially, the speed of the optical blood flow measurement can
be substantially increased. The scheme facilitates blood flow monitoring
of highly scattering tissues in geometries wherein light propagation is
diffusive or non-diffusive, and it is particularly well-suited for utilization
with pressure measurement paradigms that employ differential flow signals
to reduce contributions of superficial tissues.
© 2014 Optical Society of America
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1. Introduction
Diffuse optical techniques, such as near-infrared or diffuse optical spectroscopy (DOS, NIRS)
and diffuse correlation spectroscopy (DCS), have been employed with remarkable success over
the last two decades to probe hemodynamic processes in highly scattering tissues such as human
brain, muscle and breast [1–11]. In total, this research has discovered new indicators of tissue
function and health that are proving to be clinically relevant [6–14]. The most basic DOS/NIRS
instrument measures diffuse reflectance from tissue as a function of input wavelength, and
thereby derives the concentration of tissue chromophores and contrast agents, including oxy-
and deoxy-hemoglobin (HbO2, Hb), and changes thereof. Diffuse correlation spectroscopy
(DCS), by contrast, is a more recently developed optical technique that utilizes the temporal
intensity fluctuations of multiply scattered light in order to quantify microvascular blood flow
in highly scattering tissues [13–15]. Like DOS/NIRS, the DCS method is non-invasive and
penetrates tissue deeply, but DCS also offers the possibility to directly measure the “blood
flow” contribution to tissue hemodynamics, continuously and at the bedside.
In this contribution we develop and validate a Modified Beer-Lambert law for measurement
of blood flow based on the DCS technique. This method linearly relates measured changes of a
newly-defined “DCS optical density” to the variation of tissue blood flow, tissue scattering, and
tissue absorption. The novel algorithm parallels the DOS/NIRS Modified Beer-Lambert law,
but it has interesting differences that should be useful for applications that require continuous
monitoring of blood flow.
Traditional optical spectroscopy measures the attenuation of light traveling through a sample
as a function of wavelength. In cases where scattering is negligible, i.e., in which the reduced
scattering coefficient (µ ′s) is zero, light attenuation is dominated by absorption, and the
transmitted intensity (I(t)) at time t is related to the sample absorption coefficient (µa) via
the Beer-Lambert law: I(t) = Is exp[−µaρ]. Here, Is is the incident light intensity, and ρ is the
sample length. The sample optical density (OD) is defined as the negative logarithm of the ratio
of transmitted to incident light intensity; it is proportional to the absorption coefficient, i.e.,
OD ≡ − log[I(t)/Is] = µaρ . When scattering within the sample is significant, however, then
light attenuation is affected by both absorption and scattering. In these situations, the effects
of scattering become tangled with those of absorption [1]. Typically, the photon trajectories
through tissue samples with significant scattering are well approximated as random walks, and
the average length of a photon path through tissue is much greater than the straight-line distance
between source and detector.
Among the most widely used approaches for analysis of such DOS/NIRS reflectance signals
is the so-called Modified Beer-Lambert law [16–18]. The Modified Beer-Lambert paradigm is
an algorithm that derives changes in tissue optical properties based on continuous-wave (CW)
diffuse optical intensity measurements. In its simplest form, the scheme relates differential
light transmission changes (in any geometry) to differential changes in tissue absorption. Here
the term differential refers to a comparison between a baseline state and a perturbed state.
In essence, the Modified Beer-Lambert law accounts for tissue scattering by using the mean
pathlength traveled by photons through the highly scattering sample as a best estimate for the
actual photon pathlengths. The mean pathlength provides a natural constant of proportionality
between the measured differential intensity and the sample’s differential absorption.
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The Modified Beer-Lambert law is readily derived from the first order Taylor expansion
of the optical density: OD ≈ OD0 +(∂OD0/∂µa)∆µa +(∂OD0/∂µ ′s)∆µ ′s, wherein the partial
derivatives are evaluated in the “baseline” state (µa = µ0a , µ ′s = µ ′0s ), OD0 ≡− log[I0/Is] is the
baseline optical density, and the differential changes in absorption and scattering are denoted
by ∆µa ≡ µa(t)−µ0a and ∆µ ′s ≡ µ ′s(t)−µ ′0s , respectively. Note that the superscript “0” indicates
baseline. Within this approximation, the change in optical density from baseline is
∆OD =− log
(
I(t)
I0
)
≈ 〈L〉∆µa(t)+
(
µ0a
µ ′0s
)
〈L〉∆µ ′s(t)≈ 〈L〉∆µa(t). (1)
Here, 〈L〉 ≡ ∂OD0/∂µa is the so-called differential pathlength, which is approximately the
mean pathlength that diffusing photons travel through the medium from source to detector [17].
Notice that whereas the traditional Beer-Lambert law relates absolute optical densities to
absolute absorption coefficients, the Modified Beer-Lambert law (Eq. (1)) relates differential
changes in the optical density to differential changes in the absorption coefficient. This
algorithm has proved useful for many reasons; it is simple, fast, and fairly accurate. To date the
Modified Beer-Lambert algorithms have been applied predominantly to monitor hemoglobin
concentration changes in the brain; within this context, it has been extended from semi-
infinite geometries to two-layer geometries [18–22] characteristic of many tissues, especially
the human head.
Herein, we derive a Modified Beer-Lambert law for measurement of blood flow based
on the DCS technique in turbid tissues, and we validate the approach. The Modified Beer-
Lambert law for blood flow linearly relates changes in tissue blood flow, tissue scattering,
and tissue absorption to variation of a newly-defined “DCS optical density” (ODDCS). The
new algorithm parallels the DOS/NIRS Modified Beer-Lambert law, since the transport of
both the light fluence rate and the electric field autocorrelation function through highly
scattering tissues is well approximated as a diffusive process [1]. Importantly, however, the
diffusion equation for the DCS signal is sensitive to the movement of red blood cells in
tissue microvasculature, and therefore the precise form of the Modified Beer-Lambert law for
blood flow is different from the traditional (DOS/NIRS) form. The weighting factors in the
new law, for example, are not as easily interpreted in terms of a mean pathlength. We derive
general theoretical results for measurement of flow changes in any geometry, and then we
obtain specific expressions for two common tissue models: homogeneous semi-infinite turbid
media and two-layer turbid media. We demonstrate the new approach with simulations and
with an in-vivo pig-brain experiment. In the future, we expect the Modified Beer-Lambert
law for flow to offer increased DCS measurement speed, simpler DCS instrumentation, and,
importantly, access to novel measurement paradigms based on differential blood flow signals.
Ultimately, these developments should lead to improvements in characterization of cerebral
flow and metabolism, with concomitant clinical impact.
2. Diffuse correlation spectroscopy
Diffuse correlation spectroscopy (DCS) employs NIR light to non-invasively measure tissue
blood flow. Since early work with in-vitro phantoms and in-vivo tissues [15,23–25], it has been
used in a variety of clinical applications such as stroke [26–29], brain injury [30, 31], muscle
disease [32–34], cancer [35–38], and in functional activation studies [39–42]. In addition, the
DCS blood flow index has been successfully validated against a plethora of gold-standard
techniques [3,43]. Several recent reviews highlight the theory, implementation and applications
of DCS [1, 3, 13, 14, 44], and therefore our background discussion will be brief.
DCS detects tissue blood flow using speckle correlation techniques. It measures the temporal
intensity fluctuations of coherent NIR light that has scattered from moving particles (red blood
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Fig. 1. (A) Schematic for blood flow monitoring in a homogeneous, semi-infinite turbid
tissue (see text for details). Blood cell (e.g., red disks at time t and light-red disks at
time t + τ) motion induces temporal fluctuations in the scattered light intensity, I(t), at the
light detector (panel B). These intensity fluctuations are characterized by the normalized
intensity autocorrelation function (g2(τ)). (C) The decay of the intensity autocorrelation
function curves is related to tissue blood flow.
cells) in tissue (Fig. 1(A)). These temporal fluctuations (Fig. 1(B)) are quantified by computing
the normalized intensity temporal autocorrelation function at multiple delay-times, τ , i.e., we
compute g2(τ)≡ 〈I(t)I(t + τ)〉/〈I(t)〉2, where I(t) is the intensity of the detected light at time
t, and the angular brackets, 〈〉, represent time-averages. An index of tissue blood flow is then
provided by the temporal decay of the detected intensity autocorrelation function (Fig. 1(C)).
Formally, the transport of the electric field (E(t)) autocorrelation function, G1(τ)≡ 〈E∗(t) ·
E(t+τ)〉, is well modeled by the so-called correlation diffusion equation [15,23], which can be
solved analytically or numerically for tissue geometries of interest [1,15]. Tissue blood flow can
be ascertained by fitting the solution for the normalized electric field autocorrelation function,
g1(τ) = G1(τ)/G1(τ = 0), to the measured (normalized) intensity autocorrelation function via
the Siegert relation [45]: g2(τ) = 1+β |g1(τ)|2, where β is a constant determined primarily by
the experimental collection optics.
As an example, for the simple case of point illumination and point detection on the surface of
semi-infinite homogeneous tissue (Fig. 1(A)) with absorption coefficient µa, reduced scattering
coefficient µ ′s, and tissue blood flow index F , the solution to the correlation diffusion equation
is [1, 15]:
G1(τ) =
3
4pi`tr
[
exp(−K(τ)r1)
r1
− exp(−K(τ)rb)
rb
]
. (2)
Here, K(τ)= [3µa(µa+µ ′s)(1+2µ ′sk20Fτ/µa)]
1/2, r1 =(`2tr+ρ2)1/2, rb = [(2zb+`tr)2+ρ2]1/2,
ρ is the source-detector separation, and `tr = 1/(µa+µ ′s). Further, k0 = 2pin/λ is the magnitude
of the light wave vector in the medium, and zb = 2`tr(1+Re f f )/(3(1−Re f f )), where Re f f is the
effective reflection coefficient that accounts for the mismatch between the index of refraction of
tissue (n) and the index of refraction of the non-scattering medium bounding the tissue (nout ),
such as air [46].
A standard approach for blood flow monitoring with DCS in this geometry is to derive
g1(τ) from measurements of g2(τ) via the Siegert relation. Then, the semi-infinite correlation
diffusion solution (Eq. (2)) is fit to g1(τ) using a nonlinear minimization algorithm, and an
estimate of the blood flow index (F) is obtained from the fit.
3. Modified Beer-Lambert law for flow
We now develop a “Modified Beer-Lambert law” for tissue blood flow based on the DCS
measurement. The first step in this process is to define a “DCS optical density” (ODDCS), in
analogy with the OD for DOS/NIRS. For source-detector separation ρ and delay-time τ , we
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define the DCS optical density as: ODDCS(τ,ρ) ≡ − log(g2(τ,ρ)−1). Notice that in addition
to delay time and source-detector separation, the DCS optical density also implicitly depends
on tissue absorption, scattering, and blood flow (e.g, Eq. (2)).
3.1. DCS Modified Beer-Lambert law for homogeneous tissue
We first derive a general expression for homogeneous tissue characterized by a blood flow
index, F , an absorption coefficient, µa, and a reduced scattering coefficient, µ ′s. The DCS
Modified Beer-Lambert law is obtained by truncating the Taylor series expansion of the DCS
optical density to first order in F , µa, and µ ′s, i.e.,
ODDCS(τ,ρ)≈ OD0DCS(τ,ρ)+
∂OD0DCS
∂F
∆F +
∂OD0DCS
∂µa
∆µa+
∂OD0DCS
∂µ ′s
∆µ ′s. (3)
Here, OD0DCS(τ,ρ)≡− log(g02(τ,ρ)−1) is the “baseline” DCS optical density with a baseline
blood flow index, F0, and with baseline optical properties µ0a and µ ′0s . Correspondingly,
ODDCS(τ,ρ)≡− log(g2(τ,ρ)−1) is the DCS optical density for the intensity autocorrelation
function in the “perturbed” state with blood flow index F , and with optical properties µa and
µ ′s. The differential changes from baseline of tissue blood flow, absorption, and scattering are
∆F ≡ F−F0, ∆µa ≡ µa−µ0a , and ∆µ ′s ≡ µ ′s−µ ′0s , respectively.
Comparing Eq. (3) with Eq. (1), the DCS analogues of the differential pathlength are
dF(τ,ρ) ≡ ∂OD0DCS/∂F , da(τ,ρ) ≡ ∂OD0DCS/∂µa, and ds(τ,ρ) ≡ ∂OD0DCS/∂µ ′s, which can
be estimated analytically or numerically using the correlation diffusion model applied to the
appropriate geometry (Appendix 1). All three of these weighting factors depend on τ and ρ , on
tissue geometry, and on the baseline parameters F0, µ0a , and µ ′0s . Rearranging Eq. (3), we arrive
at the “DCS” Modified Beer-Lambert law for homogeneous tissue:
∆ODDCS(τ,ρ) =− log
(
g2(τ,ρ)−1
g02(τ,ρ)−1
)
≈ dF(τ,ρ)∆F +da(τ,ρ)∆µa+ds(τ,ρ)∆µ ′s. (4)
If the blood flow and optical properties change only slightly, then the perturbation in the
DCS optical density is small, and the first order expansion (Eq. (3)) is a good approximation.
Notice, however, that even for large tissue hemodynamic changes, ∆ODDCS can still be small
at short delay-times, because in this limit, dF , da, and ds are close to zero (Fig. 2). Analytical
and numerical computation of these weighting factors (dF , da, ds) are described and given in
Appendix 1.
Eq. (4) is a general result that describes the change in DCS optical density for homogeneous
tissue. For a given tissue/measurement geometry, the change in blood flow can be computed by
evaluating the weighting factors for the geometry in question, and then inserting these resultant
weighting factors into Eq. (4).
3.2. DCS Modified Beer-Lambert law for homogeneous semi-infinite geometries
It is straightforward to evaluate the weighting factors in Eq. (4) for the special case of the
homogeneous semi-infinite geometry (Fig. 1(A)). Recall from Eq. (2) that the normalized
electric field autocorrelation function is
g1(τ) =
exp(−K(τ)r1)/r1− exp(−K(τ)rb)/rb
exp(−K0r1)/r1− exp(−K0rb)/rb , (5)
where K(τ), r1, and rb are as defined in Section 2, and K0 = K(τ = 0) = [3µa(µa + µ ′s)]1/2.
The multiplicative weighting factors in the semi-infinite geometry can be computed from
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Fig. 2. (A) The semi-infinite multiplicative weighting factors (see Eq. (4)) for tissue
scattering (ds), for tissue absorption (da), and for tissue blood flow (dF , right vertical-axis).
They are plotted as a function of the correlation time, τ , for source-detector separation,
ρ = 3 cm, and optical wavelength, λ = 785 nm, given a typical set of cerebral tissue
properties, i.e., µ0a = 0.1 cm−1, µ ′0s = 8 cm−1, F0 = 10−8 cm2/s, n = 1.4, nout = 1. (B)
The semi-infinite DCS Modified Beer-Lambert components dF (τ,ρ)∆F , ds(τ,ρ)∆µ ′s, and
|da(τ,ρ)∆µa|, plotted as a function of τ for a 10% increase in blood flow, tissue scattering,
and tissue absorption, respectively. On the right vertical-axis is the intensity autocorrelation
function, g02(τ), for β = 0.5. Given the same fractional change in tissue properties, the
DCS signal is most sensitive to scattering changes, followed by flow changes, and finally
absorption changes. In many applications, however, the scattering changes associated with
hemodynamic perturbations are negligible, e.g., such as an increase in blood flow and blood
volume; in these situations the scattering component can be neglected (see text).
substitution of Eq. (5) into Equations (A.1) and (A.2), e.g.,
dF(τ,ρ) =
6µ ′0s
(
µ ′0s +µ0a
)
k20τ
K0(τ)
[
exp
(−K0(τ)r01)− exp(−K0(τ)r0b)
exp
(−K0(τ)r01)/r01− exp(−K0(τ)r0b)/r0b
]
. (6)
In Fig. 2, dF , da, and ds in the semi-infinite geometry are plotted as a function of τ using
typical tissue properties. Note that all three weighting factors are small in magnitude for
short delay-times. Further, the weighting factor for absorption is negative, i.e., an increase
in absorption is accompanied by a decrease in the DCS flow optical density (compared to
baseline), and the weighting factors for flow and scattering are positive.
Because the weighting factors are small at shorter delay-times (Fig. 2), the DCS optical
density perturbation will also be small, which in turn implies higher accuracy for the DCS
Modified Beer-Lambert law (Eq. (4)). Ideally, in the semi-infinite geometry, the delay-times
used for Eq. (4) should satisfy the limits 2µ ′sk20Fτ/µa  1 and 2µ ′0s k20F0τ/µ0a  1 to obtain
the most quantitatively accurate results (see Appendix 2). From our experience with simulations
and real data, we have found that a good “rule of thumb” for accurately using Eq. (4) is to utilize
data wherein g01(τ)> 0.5, which corresponds to g
0
2(τ)> 1.1 for β = 0.5.
Figure 2(B) shows that for the same fractional changes (10%) in blood flow, tissue scattering,
and tissue absorption, the change in DCS optical density is greatest due to scattering, followed
by flow; changes in absorption have the least influence on the DCS signal. In practice,
concurrent frequency-domain or time-domain DOS/NIRS can (and should) be employed to
directly measure tissue absorption and scattering [1, 47, 48] and account for their effects. This
mode of operation, i.e., with concurrent optical measurements, is always desirable. Importantly,
however, the tissue scattering changes that typically accompany hemodynamic concentration
variations are often negligible; the origin of hemodynamic variation is blood, but the origin
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of tissue scattering is predominantly from interfaces between cells and the extracellular space,
or between cellular cytoplasm and cellular organelles [49]. The tissue blood volume (BV ) is
typically a small fraction (< 4%) of the tissue volume (Vtissue), and red blood cells account for
only a small fraction of the tissue scattering [50]. Scattering from blood (µ ′s,blood) is proportional
to the blood volume, i.e., µ ′s,blood = σblood(1− g)(Hct/VRBC)(BV/Vtissue), where σblood, g,
and VRBC are the scattering cross-section, scattering anisotropy factor, and volume of a red
blood cell, and Hct is the hematocrit. Consequentially, while tissue scattering can change with
variation in blood volume, the magnitude of this change is often quite small, because the overall
volume fraction of blood in tissue is quite small.
As an example, the finger tapping functional task induces a localized increase in cerebral
blood volume of roughly 10% [39], which corresponds approximately to a 10% increase in
scattering from blood. However, the fractional increase in total scattering is much less than
10% because blood only accounts for a small fraction of tissue scattering. If we assume that
blood accounts for less than 5% of total tissue scattering [49], then the tissue scattering change
due to increased blood volume from finger tapping is less than 0.5%.
3.3. DCS Modified Beer-Lambert law for heterogeneous tissue
Tissue is perhaps too often approximated to be optically homogeneous for hemodynamic
monitoring, an approach which has the advantage of simplicity. Realistically, however, tissue
is heterogeneous; it contains multiple compartments with different optical properties due to
vasculature, fat, and bone. Often these regions arise as “layers” below the tissue surface such as
scalp, skull, and cortex. Under these conditions, a Taylor series expansion of the DCS optical
density can also be used to derive the DCS Modified Beer-Lambert law for heterogeneous
media. Assuming that the heterogeneous tissue can be divided into N piecewise homogeneous
regions, then the first-order Taylor series expansion of the DCS optical density is
ODDCS(τ,ρ)≈ OD0DCS(τ,ρ)+
N
∑
k=1
[
∂OD0DCS
∂Fk
∆Fk +
∂OD0DCS
∂µa,k
∆µa,k +
∂OD0DCS
∂µ ′s,k
∆µ ′s,k
]
. (7)
Here, Fk, µa,k, and µ ′s,k denote the blood flow index, tissue absorption, and tissue scattering for
the kth homogeneous region in the tissue, respectively, and ∆Fk ≡ Fk−F0k , ∆µa,k ≡ µa,k−µ0a,k,
and ∆µ ′s,k ≡ µ ′s,k − µ ′0s,k denote the changes in these parameters from baseline. Rearranging
Eq. (7), the DCS Modified Beer-Lambert law for heterogeneous media is:
− log
(
g2(τ,ρ)−1
g02(τ,ρ)−1
)
≈
N
∑
k=1
[
dF,k(τ,ρ)∆Fk +da,k(τ,ρ)∆µa,k +ds,k(τ,ρ)∆µ ′s,k
]
, (8)
where {dF,k ≡ ∂OD0DCS/∂Fk, da,k ≡ ∂OD0DCS/∂µa,k, ds,k ≡ ∂OD0DCS/∂µ ′s,k} are DCS analogues
of the partial pathlengths from DOS/NIRS [18]. These multiplicative weighting factors depend
on tissue geometry, on the baseline tissue properties, i.e., {F0k , µ0a,k, µ ′0s,k}, and on τ and ρ .
They account for the relative importance of the various regional hemodynamic changes in the
DCS optical density perturbation, and they can be estimated in the same manner as described
in Appendix 1.
3.4. DCS Modified Beer-Lambert law for two-layer media
The simplest heterogeneous model for tissue is the two-layer geometry, an important special
case (Fig. 3). Researchers have used this geometry in order to distinguish cerebral tissue from
extra-cerebral tissue in optical measurements of the head [22,39,51–55], to model tissue burns
[15], to distinguish skin from fat/muscle [56,57], to distinguish fetal from maternal tissues [58],
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Fig. 3. (A) Two-layer tissue model of the head and (B) parallel plane two-layer tissue
geometry.
and in other applications. For cerebral applications, the two-layer geometry is comprised of
a semi-infinite bottom layer (i.e., corresponding to the cortical regions of the brain) with a
distinct blood flow index, absorption coefficient, and scattering coefficient of Fc, µa,c, and µ ′s,c,
respectively, and a superficial top layer (i.e., corresponding to extra-cerebral scalp and skull
tissue) with thickness `, and distinct tissue properties denoted by Fec, µa,ec, and µ ′s,ec.
The two-layer DCS Modified Beer-Lambert law is the special case of Eq. (8) for N = 2
piecewise homogeneous (layered) regions, i.e.,
∆ODDCS(τ,ρ) =− log
(
g2(τ,ρ)−1
g02(τ,ρ)−1
)
≈ dF,c(τ,ρ)∆Fc+dF,ec(τ,ρ)∆Fec+
da,c(τ,ρ)∆µa,c+da,ec(τ,ρ)∆µa,ec+ds,c(τ,ρ)∆µ ′s,c+ds,ec(τ,ρ)∆µ
′
s,ec. (9)
Again, the multiplicative weighting factors, dF,i ≡ ∂OD0DCS/∂Fi, da,i ≡ ∂OD0DCS/∂µa,i, and
ds,i ≡ ∂OD0DCS/∂µ ′s,i (with subscript i denoting c (cerebral) or ec (extra-cerebral)), indicate
the relative sensitivity of the DCS optical density variation to cerebral versus extra-cerebral
hemodynamic changes. All six parameters depend on delay-time τ , source-detector separation
ρ , top layer thickness `, and baseline tissue properties F0c , F0ec, µ0a,c, µ0a,ec, µ ′0s,c, and µ ′0s,ec. They
can be computed by numerically taking the appropriate derivatives of the two-layer solution to
the correlation diffusion equation. For the parallel plane two-layer geometry (Fig. 3(B)), the
solution is [15, 54]:
g1(τ) = G1(τ)/G1(0),
G1(τ) =
1
2pi
∫ ∞
0
G˜1(τ)sJ0(sρ)ds,
G˜1(τ) =
sinh[κec(zb+ z0)]
Decκec
Decκec cosh[κec`]+Dcκc sinh[κec`]
Decκec cosh[κec(`+ zb)]+Dcκc sinh[κec(`+ zb)]
− sinh[κecz0]
Decκec
,
where Di = 1/[3(µ ′s,i + µa,i)], κ2i = (Dis2 + µa,i + 2µ ′s,ik20Fiτ)/Di, zb = 2Dec(1+Re f f )/(1−
Re f f ), z0 = 3Dec, and Re f f and k0 are defined in Section 2 (this solution assumes the top and
bottom layers have the same optical index of refraction).
The two-layer weighting factors for a typical set of extra-cerebral/cerebral tissue properties
are plotted in Fig. 4. Importantly, for a source-detector separation ρ = 3 cm, the change in
the DCS optical density is more sensitive to changes in flow and absorption in the cerebral
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Fig. 4. (A) The two-layer multiplicative weighting factors (see Eq. (9)) for dF,c and dF,ec
(right vertical-axis); and for da,c, da,ec, ds,c, and ds,ec. They are plotted as a function of the
correlation time, τ , for source-detector separation, ρ = 3 cm, and optical wavelength, λ =
785 nm, given a set of typical extra-cerebral and cerebral tissue properties [51], i.e., µ0a,c =
0.16, µ0a,ec = 0.12, µ ′0s,c = 6, µ ′0s,ec = 10 cm−1; F0c = 10−8, F0ec = 10−9 cm2/s; ` = 1 cm,
n= 1.4, and nout = 1. (B) The two-layer DCS Modified Beer-Lambert components dF,c∆Fc,
dF,ec∆Fec, |da,c∆µa,c|, and |da,ec∆µa,ec|, plotted as a function of τ for a 10% increase in
each parameter. On the right vertical-axis is the intensity autocorrelation function, g02(τ),
for β = 0.5. Notice that at shorter delay-times for ρ = 3 cm, the change in DCS optical
density is equally sensitive to changes in cerebral blood flow, extra-cerebral blood flow, and
cerebral absorption. The change in DCS optical density (ODDCS) is less sensitive, however,
to changes in extra-cerebral absorption. (C) The ratio of the cerebral (c) and extra-cerebral
(ec) flow components in the DCS optical density perturbation, ∆ODDCS(τ) (Eq. (9)), for 4
separations, ρ = 0.5, 1, 2, and 3 cm. These data are plotted as a function of τ assuming a
10% increase in cerebral and extra-cerebral blood flow. For the shorter separations of 0.5
and 1 cm, the ratio is substantially less than one; in this case, the DCS optical density is
predominantly sensitive to the extra-cerebral layer. At the 3 cm separation, the DCS optical
density is more sensitive to cerebral blood flow than extra-cerebral blood flow at the short
delay-times, i.e., the ratio is greater than one. However, at longer delay-times, the ratio
decreases. (D) The ratio of the cerebral and extra-cerebral absorption components in the
two-layer Modified Beer-Lambert law for DOS/NIRS, plotted as a function of ρ for a 10%
increase in cerebral and extra-cerebral absorption. 〈L〉c and 〈L〉ec are the cerebral and extra-
cerebral partial pathlengths [18, 21]. Notice from panels (C) and (D) that the DCS optical
density is more sensitive to the cerebral layer than the NIRS optical density is, consistent
with findings in work of reference [59].
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layer than in the extra-cerebral layer (except for at very long delay-times). This sensitivity is
especially prominent at the shorter delay-times (Figs. 4(B), 4(C)). In practice the situation is
helped by differences in magnitude of cerebral versus extra-cerebral flow (e.g., cerebral flow
is quite often 10 times larger than extra-cerebral flow) [60]. We note here that the sensitivity
to cerebral flow changes (Fig. 4(C)) depends on the specific ratio of cerebral to extra-cerebral
flow [59]. For example, if F0c = 6F
0
ec, the ratio of the cerebral flow component (dF,c∆Fc) to extra-
cerebral flow component (dF,ec∆Fec) is 0.7 at short delay-times for ρ = 3 cm (compared to 1.15
for F0c = 10F
0
ec in Fig. 4(C)). Further, this ratio depends on the extra-cerebral layer thickness,
because the NIR light intensity is exponentially attenuated with increasing tissue depth. For
example, if the extra-cerebral layer thickness is increased to ` = 1.1 cm, then the ratio of the
flow components in Fig. 4(C) at short delay-times is 0.8 for ρ = 3 cm.
The increase in the influence of the extra-cerebral layer at longer delay times (Fig. 4(C))
can be explained from consideration of the pathlengths of light, specifically their association
with short versus long correlation decay times τ . Briefly, in the temporal autocorrelation
function, long light paths contribute to rapid decays of the signal (short τ) and short light paths
contribute to slow decays of the signal (large τ) [61, 62]. Short source-detector separations,
e.g., ρ = 0.5 cm, mostly sample the superficial layer, and the DCS optical density perturbation
is predominantly sensitive to the superficial layer in this case (Fig. 4(C)). Interestingly, a
comparison of Figs. 4(C) and 4(D) reveals that the DCS optical density is more sensitive
to cerebral changes than the DOS/NIRS optical density (consistent with findings of Selb et
al [59]). Again, this effect arises in part because cerebral blood flow is much greater than
extra-cerebral blood flow, and in part because DCS is effectively a time-resolved technique
that permits separation of long light paths (shorter delay-times) from short light paths (longer
delay-times) [59].
4. Results
4.1. Validation with simulated data
We tested the semi-infinite DCS Modified Beer-Lambert law (Eq. (4)) using simulated data
(Fig. 5), as well as real data collected from a juvenile pig (Figs. 7, 8). The simulated DCS
data was generated from semi-infinite analytical solutions of the correlation diffusion equation
(Eq. (5)) with added noise [63]. Baseline tissue blood flow and optical properties in the
simulated data were chosen to be representative of the head [64], and perturbations from
baseline were induced by varying blood flow (F) from +50% to −50%, with constant tissue
optical properties. Figure 5(A) shows the simulated intensity autocorrelation functions for these
baseline and perturbed conditions, plotted as a function of delay-time. The DCS Modified Beer-
Lambert law (Eq. (4)) was then applied to this simulated data set to calculate the flow change
as a function of delay-time (Fig. 5(B)). Good agreement between the calculated and actual flow
changes is found for a wide range of delay-times.
We next quantified the range of delay-times for which the DCS Modified Beer-Lambert law
can be accurately employed. First, recall that the semi-infinite DCS Modified Beer-Lambert
law is expected to be accurate in the limit 2µ ′sk20Fτ/µa  1 (Appendix 2). The simulations
show that it will remain fairly accurate even when 2µ ′sk20Fτ/µa ∼ 1. In order to appreciate the
simulation results more generally, we introduce the dimensionless delay-time, τγ0F0, which
depends on baseline blood flow (F0), correlation time-delay (τ), and γ0 ≡ K00 (µ ′0s /µ0a )k20r01
(see Eq. (B.4)). When this dimensionless delay-time is ∼ 1, then the baseline electric field
autocorrelation function has decayed by ∼ 1/e. In terms of this dimensionless delay-time,
the limit 2µ ′sk20Fτ/µa  1 corresponds to the baseline condition τγ0F0  α , where α ≡
γ0µ0a/(2µ ′0s k20). For the “typical” conditions chosen for Fig. 5, α = 2.3.
Figure 5(B) plots the calculated DCS Modified Beer-Lambert flow change for each
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Fig. 5. (A) Simulated semi-infinite intensity autocorrelation curves (mean ± SD across
N = 10k curves) plotted as a function of the delay-time τ for a −50% and +50%
change in flow while tissue optical properties were held constant. The source-detector
separation, light wavelength, and baseline tissue properties are ρ = 3 cm, λ = 785 nm,
and µ0a = 0.1 cm−1, µ ′0s = 8 cm−1, F0 = 10−8 cm2/s, n = 1.4, nout = 1, respectively.
The simulated DCS data were generated from the semi-infinite solution of the correlation
diffusion equation (Eq. (5)) with added noise derived from a correlation noise model [63].
The correlation noise model was evaluated at a baseline DCS intensity of 50k photons a
second and an averaging time of 2.5 seconds. (B) Fractional blood flow changes (mean
± SD) estimated by applying the semi-infinite DCS Modified Beer-Lambert law, i.e.,
rb f (τ) = ∆ODDCS(τ)/(dF (τ)F0) (Eq. (4)), to the simulated data. To appreciate the
simulated results more generally, these fractional blood flow changes are plotted against
the dimensionless delay-time τγ0F0. Here, (γ0F0)−1, where γ0 ≡ K00 (µ ′0s /µ0a )k20r01 (see
Eq. (B.4)), is approximately the characteristic decay time of the baseline electric field
autocorrelation function (see Appendix 2).
dimensionless delay-time. The difference (error) between the calculated flow change and the
true flow change (simulated value) is relatively small, even for dimensionless delay-times
approaching α = 2.3. We also see that for a 50% increase in flow, the DCS Modified Beer-
Lambert law is accurate over a narrower range of dimensionless delay-time than for a 50%
decrease (Fig. 5(B)). The latter behavior is a consequence of the fact that when flow is
increased, the intensity autocorrelation function decays more rapidly. When the autocorrelation
curves are close to fully decayed, then the DCS Modified Beer-Lambert law is predominantly
sensitive to correlation noise instead of flow. For a perturbed state from baseline (e.g., rb f =
50%), the limit 2µ ′sk20Fτ/µa 1 corresponds to τγ0F0α(F0/F) (assuming constant optical
properties). Thus, a larger value of F reduces the value of the dimensionless delay-time upper
limit.
4.2. Noise consideration
At very short delay-times, there is little difference between the intensity autocorrelation curves
corresponding to different blood flows (Fig. 5(A)). In this limit, the changes to the DCS optical
density are heavily influenced by correlation noise, and flow calculations at the very short delay-
times in Fig. 5(B) are noisy. In general, from applying error propagation rules to Eq. (4), the
noise in the calculated flow change (δ (rb f (τ))) as a function of τ for constant tissue optical
properties is
δ (rb f (τ)) =
1
dF(τ)F0
δ (∆ODDCS(τ)) =
1
dF(τ)F0
δ (g2(τ)−1)
|g2(τ)−1| . (10)
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Fig. 6. (A) To monitor hemodynamics in the semi-infinite geometry, a juvenile pig’s scalp
was reflected, and 2.5 mm burr holes were drilled through the skull for placement of 90-
degree optical fibers. A DOS/NIRS source-detector pair (red circles) measured cerebral
tissue absorption, and a DCS source-detector pair (black circles) measured cerebral blood
flow. The source-detector separation of both pairs is ρ ≈ 1.5 cm. (B) Schematic showing
the timeline of the experiment in minutes. Venous infusion of dinitrophenol (DNP, 9
mg/kg) dramatically stimulated cerebral oxygen metabolism and induced a 200% increase
in cerebral blood flow. The DCS and DOS techniques were interleaved to measure blood
flow and tissue absorption every 7 seconds. (C) Anterior-posterior slice of an anatomical
MRI scan of a pig with similar weight to the juvenile pig used in this measurement. The
burr holes for the two optical fibers closest to the midline in panel (A) have been artificially
overlayed on this scan.
A correlation noise model can be used to accurately estimate δ (g2(τ)−1) [63]. As τ increases,
the correlation noise decreases, and dF(τ)F0 increases (Fig. 2(A)). Both trends reduce the noise
in rb f . However, when |g2(τ)− 1| goes to zero as τ increases, an accompanying increase in
noise is expected. From Fig. 5(B), the noise in rb f falls with increasing delay-time and then
levels off around τγ0F0 ≈ 0.3; the noise then remains constant for a large range of delay-times.
As one would expect, the flow change computed with a single τ in the DCS Modified Beer-
Lambert law is more sensitive to noise than the flow change extracted from nonlinear fits to the
semi-infinite correlation diffusion solution across many delay-times. To ameliorate sensitivity
to noise, multiple delay-times can also be used for the DCS Modified Beer-Lambert law. Then
Eq. (4) becomes a system of linear equations, i.e., one equation for each delay-time, which can
very rapidly be solved to derive flow changes.
4.3. In-vivo validation
Finally, we validated the semi-infinite DCS Modified Beer-Lambert law in-vivo. In this case, the
scalp of a juvenile pig was reflected and 2.5-mm burr holes were drilled through the skull down
to the dura (Fig. 6). Optical fibers were inserted into the holes to comprise a single DCS source-
detector pair for measurement of cerebral blood flow, and a single DOS/NIRS source-detector
pair for measurement of cerebral tissue absorption (Fig. 6(A)). The source-detector separations
of both pairs were approximately 1.5 cm, and the baseline cerebral optical properties of the pig
were assumed to be µ0a (785 nm) = 0.2 and µ ′0s (785 nm) = 8 cm−1 [65]. Importantly, in this
measurement the semi-infinite geometry is a good approximation for the true tissue geometry,
because the optical fibers are very close to the brain.
Figure 6(B) is a schematic showing the timeline of the experiment. While monitoring with
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Fig. 7. Temporal fractional cerebral blood flow changes induced by injection of the drug
dinitrophenol (DNP) in a juvenile pig. The baseline flow is F0 = 5.34×10−8 cm2/s, which
is the average blood flow index over the 18 minute time interval between the vertical dashed
lines. Cerebral blood flow changes were calculated from nonlinear fits to the semi-infinite
correlation diffusion solution (Eq. (5)) and from the semi-infinite DCS Modified Beer-
Lambert law (Eq. (4)) using (A) multiple delay-times, i.e., τ < 5.5 µs, which corresponds
to g02(τ) > 1.25, and (B) a single delay-time, i.e., τ = 3.8 µs, which corresponds to
g02(τ) = 1.3. Measured tissue absorption changes (Fig. 8(B)) were incorporated in both
the correlation diffusion fit and the DCS Modified Beer-Lambert law. Tissue scattering was
assumed to remain constant at µ ′s = 8 cm−1, and the red and blue shaded regions indicate
quasi steady-state temporal intervals that are analyzed further in Fig. 8.
DOS and DCS, a 200% increase in cerebral blood flow was induced in the pig via venous
infusion of 9 mg/kg of the drug dinitrophenol (DNP). DNP is a proton transporter across
cell membranes which disrupts the mitochondrial proton gradient [66]. In an effort to restore
the proton gradient, cells stimulate cerebral oxygen metabolism [66], which in turn leads to
a large increase in cerebral blood flow. Additional details about the animal preparation and
measurement are in Appendix 3.
The calculated temporal cerebral blood flow changes in the pig (due to DNP) using the DCS
Modified Beer-Lambert law are in good agreement with the calculated changes from nonlinear
fits to the semi-infinite solution of the correlation diffusion equation (Fig. 7). Measured cerebral
absorption changes (Fig. 8(B)) were incorporated in the blood flow calculations. Note, when
using multiple delay-times in the DCS Modified Beer-Lambert law, the noise in temporal blood
flow estimates is comparable to the nonlinear diffusion fit (Fig. 7(A)). For single τ blood flow
monitoring, the temporal blood flow noise is larger, but the average blood flow changes are
the same (Fig. 7(B)); this behavior demonstrates the feasibility of accurate single τ blood flow
monitoring with DCS. In Fig. 7(B), the dimensionless delay-time τγ0F0 = 0.33 (corresponding
to g02(τ) = 1.3) was used for single delay-time monitoring.
The estimated cerebral blood flow changes from the DCS Modified Beer-Lambert law are
also plotted as a function of dimensionless delay-time in Fig. 8(A) for two quasi steady-state
temporal intervals. During these temporal flow intervals, the blood flow changes were also
determined from nonlinear fits to the semi-infinite correlation diffusion solution. The average
blood flow changes from the nonlinear fit estimates are 185% and 64% (solid black lines). The
horizontal dashed lines in Fig. 8(A) indicate the noise in the nonlinear fit estimates of blood
flow (constant because the nonlinear correlation diffusion fit uses all delay-times). Note that
the average value of the DCS Modified Beer-Lambert law estimate of the larger flow increase
is within the noise of the nonlinear correlation diffusion fit estimate for the delay-time interval
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Fig. 8. (A) Mean fractional cerebral blood flow changes (averaged across indicated
time intervals in the legend) as a function of the dimensionless delay-time τγ0F0 (see
Fig. 5 caption) in a juvenile pig. (B) The pig’s cerebral absorption over time, which
was calculated from applying the semi-infinite Modified Beer-Lambert law (Eq. (1)) to
the measured DOS/NIRS intensity changes from baseline. Note that the shaded regions
in panel (B) indicate the temporal intervals averaged over in panel (A). The cerebral
blood flow changes in panel (A) were obtained from applying the semi-infinite DCS
Modified Beer-Lambert law (Eq. (4)) to the measured intensity autocorrelation curves and
the measured cerebral absorption changes. The horizontal solid and dashed black lines in
panel (A) indicate the fractional blood flow changes (Mean± SD) obtained from fitting the
intensity autocorrelation curves to the non-linear semi-infinite correlation diffusion solution
(Eq. (5)).
0.16 < τγ0F0 < 0.82, which corresponds to the baseline intensity autocorrelation function
range 1.15 < g02(τ) < 1.40. The smaller flow increase in Fig. 8(A) is accurate for an even
wider range of delay-times, because the intensity autocorrelation function associated with this
increase requires a longer delay-time to completely decay (see Section 4.1).
5. Discussion
The Modified Beer-Lambert approach has been employed extensively in the biomedical optics
community [2,7,67–70], in large part because of its simplicity. With this approach, researchers
have monitored temporal changes in blood oxygenation and blood volume with CW light, using
only one source-detector separation. In the present paper, we have extended the Modified Beer-
Lambert approach to the DCS measurement, and we have demonstrated the accuracy of this
extension in both simulations (Fig. 5) and in-vivo data (Figs. 7, 8). The DCS Modified Beer-
Lambert approach offers some advantages compared to the traditional analysis scheme of fitting
intensity autocorrelation data to nonlinear solutions of the correlation diffusion equation.
5.1. Real-time estimates of blood flow changes
The DCS Modified Beer-Lambert law is a linear equation relating changes in blood flow to
changes in signal for any tissue geometry. Although the correlation diffusion solution in the
semi-infinite geometry is closed form, the correlation diffusion solutions in more intricate
geometries (e.g., curved, layered) are vastly more complex, and consequentially quite time-
consuming when fitting data. With the DCS Modified Beer-Lambert approach, the correlation
diffusion solutions are needed only once to evaluate the multiplicative weighting factors at the
“baseline” tissue state, e.g., Eq. (A.3). We emphasize that even for geometries where closed
form solutions are not available, these multiplicative weighting factors can still be evaluated
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numerically. Then, blood flow changes from baseline are rapidly determined by solving a linear
equation (Eq. (4) or (8)). Consequentially, the DCS Modified Beer-Lambert law is well suited
for real-time blood flow monitoring, especially in tissue geometries that are not semi-infinite.
5.2. Blood flow monitoring in tissues wherein light propagation is non-diffusive
Diffusive light transport is not required for using the DCS Modified Beer-Lambert approach.
In blood flow monitoring applications wherein the photon diffusion model is not valid, the
multiplicative weighting factors can be evaluated using solutions of the correlation transport
equation [71, 72] instead of the correlation diffusion equation (see Appendix 1). For the tissue
geometry of interest, the correlation transport equation can be solved numerically with Monte
Carlo techniques [15,61]. Thus, the DCS Modified Beer-Lambert approach facilitates accurate
blood flow monitoring for the small source-detector separations typical of endoscopic probes,
for complex tissues that contain “non-diffusing” domains such as (arguably) cerebral spinal
fluid inside the head [73–75], and for tissues that contain very high concentrations of blood, as
in the liver [76]. In all three of these examples, the assumptions underlying the photon diffusion
model are violated, and therefore the photon diffusion model is not expected to be accurate.
Another potential application of the non-diffusive DCS Modified Beer-Lambert approach is
blood flow monitoring with visible light.
5.3. Improved depth sensitivity
The DCS Modified Beer-Lambert law permits blood flow monitoring with intensity
autocorrelation measurements at a single delay-time, in contrast to the traditional correlation
diffusion approach wherein blood flow estimates are obtained by acquiring and fitting a
full, nearly continuous, intensity autocorrelation curve. It is now well established that the
autocorrelation function decay times associated with long light paths are relatively short, while
the decay times associated with short light paths are relatively long [59, 61, 62]. Thus, the
autocorrelation function at shorter delay-times will be inherently more sensitive to deeper
tissues in remission geometries (Fig. 4), which in turn means that the sensitivity of the DCS
measurement to blood flow at deeper tissue depths is improved by using short delay-times
in the DCS Modified Beer-Lambert law. Conversely, using long delay-times improves the
sensitivity of the DCS measurement to tissue blood flow at shallow depths. This same effect
can be achieved by fitting different parts of the intensity autocorrelation curve to the correlation
diffusion model. In practice, these correlation diffusion fits still require several delay-times
spanning a significant portion of the autocorrelation curve. By using a single delay-time, the
experimenter has finer control of the measurement depth sensitivity for DCS measurements.
Note that for DCS measurements in transmission geometries [77], the autocorrelation function
at longer delay-times (short light paths) will be more sensitive to tissue adjacent to the straight
line between source and detector.
5.4. Increased temporal resolution of DCS measurements
The DCS Modified Beer-Lambert law offers new routes for increased DCS measurement
speed and for simpler instrumentation. Underlying these advantages is again blood flow
monitoring with a single delay-time. We and others have used multiple-τ hardware correlators
to measure the intensity autocorrelation function [78,79] at delay-times spanning several orders
of magnitude from ∼100 ns to ∼10 ms. Achieving sufficient SNR for deep tissue DCS
measurements (e.g., as in the brain) typically requires averaging many (N > 100) of these 10-ms
autocorrelation curves. The single delay-time cerebral blood flow monitoring in the pig shown
in Fig. 7(B) was done at τ = 3.8 µs. Thus, in this example,∼250 blood flow measurements can
be acquired in 1 ms, which can then be temporally averaged to reduce noise. In 10 ms, which is
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roughly the time required to measure a single autocorrelation curve with a multiple-τ correlator,
∼2500 blood flow measurements can be acquired and averaged. Therefore, even though single-
τ blood flow monitoring with the DCS Modified Beer-Lambert law is more sensitive to
correlation noise than multiple-τ monitoring (Fig. 7), the substantial improvement in the blood
flow sampling rate with single-τ monitoring means that enough averaging can be employed
to compensate for this additional noise while still maintaining high DCS measurement speeds.
Blood flow measurements at high acquisition rates are advantageous in several applications,
including schemes to filter out motion artifacts in exercising muscle [80]. Single-τ monitoring
also makes it possible to use single-τ hardware correlators, which are cheaper than multiple-τ
hardware correlators. Alternatively, software correlators [78] for a single delay-time could be
implemented.
5.5. Filtering contamination from superficial tissues in deep tissue flow monitoring
The same paradigms that have been developed with the Modified Beer-Lambert law to filter
contamination from superficial tissues in blood oxygenation measurements of the tissue of
interest (e.g., the brain) [20–22, 81, 82] can also be used in the DCS Modified Beer-Lambert
formulation for blood flow monitoring. In fact, these paradigms are likely to work even better
with DCS, because DCS is more sensitive to deep brain hemodynamics than continuous-wave
DOS/NIRS (Figs. 4C, 4D) [59].
Building on work done with the DOS/NIRS Modified Beer-Lambert law [21, 22], a useful
scheme for filtering superficial tissue contamination in the DCS signal is to employ two
source-detector separations. One source-detector separation should be long and the other short.
Detected light from the long separation travels through both superficial and deep layers of
tissue, but detected light at the short separation is predominantly confined to the superficial
layer. Two two-layer DCS Modified Beer-Lambert law equations (corresponding to the two
source-detector separations) can then be employed to better isolate the deep tissue blood flow
component from the superficial blood flow component. Ideally the experimenter would acquire
“initial/baseline” measurements wherein only superficial blood flow is changing.
In cerebral monitoring, one way to change superficial blood flow without affecting cerebral
blood flow is to vary the pressure of the optical probe against the head [83]. Initial
measurements acquired during probe pressure modulation can then be used to derive the
patient-specific weighting factors in the DCS Modified Beer-Lambert law. These weighting
factors would subsequently be used to filter superficial contamination in cerebral blood flow
monitoring. We will develop this idea further in a future paper.
6. Conclusion
The Modified Beer-Lambert extension to the DCS measurement is accurate enough to be useful
for blood flow monitoring. It facilitates real-time flow monitoring in complex tissue geometries,
provides a novel route for increasing DCS measurement speed, and can be used to probe tissues
wherein light transport is non-diffusive. It also can be used to filter signals from superficial
tissues.
A. Appendix 1
The multiplicative weighting factors dF , da, and ds in Eq. (4) can be estimated by taking
the appropriate derivative of the solutions to the correlation diffusion equation applied to the
appropriate geometry (e.g., semi-infinite homogeneous, etc.). First, using the Siegert relation,
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we have:
dF(τ,ρ)≡ ∂OD
0
DCS
∂F
=
∂
∂F
[− log(g02(τ,ρ)−1)]= ∂∂F [− log(β [g01(τ,ρ)]2)]
=
∂
∂F
[− log(β )−2log(g01(τ,ρ))]= 2 ∂∂F [− log(g01(τ,ρ))] . (A.1)
Similarly,
da(τ,ρ) = 2
∂
∂µa
[− log(g01(τ,ρ))] ,
ds(τ,ρ) = 2
∂
∂µ ′s
[− log(g01(τ,ρ))] . (A.2)
Here, g1(τ,ρ) is the solution to the correlation diffusion equation for the geometry of interest [1,
15], and the derivatives of the solution are evaluated at baseline conditions. In conditions where
an analytical solution for the correlation diffusion equation does not exist, the multiplicative
weighting factors can be computed numerically:
dF(τ,ρ) =
2
∆F
log
(
g1(τ,ρ,F0−∆F/2,µ0a ,µ ′0s )
g1(τ,ρ,F0+∆F/2,µ0a ,µ ′0s )
)
,
da(τ,ρ) =
2
∆µa
log
(
g1(τ,ρ,F0,µ0a −∆µa/2,µ ′0s )
g1(τ,ρ,F0,µ0a +∆µa/2,µ ′0s )
)
,
ds(τ,ρ) =
2
∆µ ′s
log
(
g1(τ,ρ,F0,µ0a ,µ ′0s −∆µ ′s/2)
g1(τ,ρ,F0,µ0a ,µ ′0s +∆µ ′s/2)
)
, (A.3)
where ∆F/F0 = ∆µa/µ0a = ∆µ ′s/µ ′0s = 10−5. Equations (A.1), (A.2), and (A.3) are important
intermediate results, which provide generalized expressions for the analytical and numerical
computation of the multiplicative weighting factors in the DCS Modified Beer-Lambert law for
any homogeneous geometry.
Evaluating these equations requires knowledge of the baseline tissue optical properties and
the baseline flow index. The baseline flow index can be obtained from a nonlinear fit of the
baseline intensity autocorrelation curve to the correlation diffusion solution (see Section 2).
The baseline tissue optical properties can either be assumed from the literature (e.g., [76])
or measured with time-domain or frequency-domain DOS/NIRS [47, 48]. For typical tissue
measurements wherein scattering does not change, the sensitivity in the computed fractional
blood flow change to assumed baseline optical properties is small (Fig. 9). For the example
of flow changes shown in Fig. 9, ±50% errors in the assumed baseline optical properties
affected the estimated fractional flow change by only ±5 percentage points (e.g., from 0.50 to
0.45). Thus, for many applications, errors in the assumed baseline optical properties have little
effect on calculated changes in blood flow. Computed fractional flow changes are a little more
sensitive to errors in baseline flow than to errors in baseline optical properties. Specifically, for
the example of flow changes in Fig. 9, ±10% errors in baseline flow affected the estimated
fractional flow change by ±5 percentage points, and ±25% errors in baseline flow affected the
estimated fractional flow change by ±10 percentage points (results not shown).
An important assumption in this approach is that the correlation diffusion equation accurately
models the electric field autocorrelation function in tissue. This assumption is valid when
using large source-detector separations, ρ  1/(µa + µ ′s), to measure highly scattering media
with isotropic dynamics [15]. The DCS Modified Beer-Lambert law, Eq. (4), however, can
also be used for correlation transport conditions wherein the correlation diffusion equation
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Fig. 9. Fractional blood flow changes (i.e., F/F0− 1) computed from applying the semi-
infinite DCS Modified Beer-Lambert law (Eq. (4)) with assumed baseline optical properties
of µ0a (vertical axis) and µ ′0s (horizontal axis) to semi-infinite simulated data with noise
(N = 1k curves). The actual blood flow and absorption changes are (A) 50% and 15%, and
(B) −50% and −15%, respectively. Tissue scattering was constant, and the actual baseline
properties (including simulated noise parameters) are identical to those in Fig. 5, e.g.,
µ0a = 0.1, µ ′0s = 8 cm−1 (denoted by dashed lines). To compute the absorption changes
from the simulated data, the Modified Beer-Lambert law (Eq. (1)) was employed. The
differential pathlength (〈L〉) in Eq. (1) was calculated from the assumed baseline optical
properties [84]. Finally, the baseline flow index, F0, was extracted from a nonlinear fit
of the simulated baseline data to the semi-infinite correlation diffusion solution (Eq. (5))
evaluated at the assumed baseline optical properties. Errors in the assumed baseline optical
properties only have small effects on the computed fractional flow change. Note that the
computed fractional blood flow changes are not exactly 50% and −50% when the exact
optical properties are assumed because of small errors arising from truncating the tissue
absorption terms in the Taylor Series expansion of the DCS optical density (Eq. (3)) to first
order.
breaks down. In this case, the derivatives in Equations (A.1) and (A.2) will have to be applied
to the solutions of the so-called correlation transport equation [71, 72], which can be solved
numerically with Monte Carlo techniques [15, 61].
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B. Appendix 2
The semi-infinite solution to the correlation diffusion equation (Eq. (5)) is approximately
exponential in the small delay-time limit, i.e., g1(τ) ≈ exp(−γFτ), with γ ≡ K0(µ ′s/µa)k20r1.
Normalizing the delay-time by the characteristic decay-time, i.e., τc = (γF)−1, is a meaningful
dimensionless way to express delay-times (Figs. 5, 8), e.g., g1 ≈ 0.4 for τγF = 1. Further, the
DCS Modified Beer-Lambert law (Eq. (4)) is a good approximation in the small delay-time
limit because − log(g2(τ)− 1) = − log(βg21) = 2γτF − log(β ) is linear with respect to F . To
derive the small delay-time limit of the semi-infinite correlation diffusion solution, first note
that if the source-detector separation, ρ , is much greater than the photon transport mean-free
path through tissue, `tr, then (see Eq. (2))
rb ≈ r1(1+ x/r21),
1
rb
≈ 1
r1
(
1− x
r21
)
, (B.1)
where x≡ 2zb(zb+ `tr). Substituting Eq. (B.1) into Eq. (2), we see that
G1(τ) =
3
4pi`tr
exp(−K(τ)r1)
r1
[
1− exp
(−K(τ)x
r1
)(
1− x
r21
)]
. (B.2)
In the limit K(τ)x/r1 1, which is satisfied at small delay-times, Eq. (B.2) simplifies further
to
G1(τ)≈ 34pi`tr
xexp(−K(τ)r1)
r21
(
K(τ)+
1
r1
)
. (B.3)
In the more stringent limit 2(µ ′s/µa)k20Fτ  1, the electric field autocorrelation function in
Eq. (B.3) is approximately exponential:
g1(τ) =
G1(τ)
G1(0)
≈ exp(−γFτ)
(
1+
γFτ
r1K0+1
)
≈ exp(−γFτ), (B.4)
where γ = K0(µ ′s/µa)k20r1 and K0 ≡ K(0) = [3µa(µa+µ ′s)]1/2.
C. Appendix 3
All animal procedures were in accordance with guidelines established by the National Institutes
of Health and approved by the Institutional Animal Care and Use Committee of the University
of Pennsylvania. Diffuse optical measurements were performed on a male Yorkshire juvenile
pig (28 kg). The animal was anesthetized with an initial intramuscular injection of ketamine (25
mg/kg), dexmedetomidine (0.025 mg/kg), and glycopyrolate (0.02 mg/kg), intubated, and then
mechanically ventilated with a mixture of ∼ 3% isoflurane in pure oxygen gas. To prepare for
hemodynamic monitoring in the semi-infinite geometry, the pig’s scalp was reflected over the
left hemisphere of the brain, and a dental drill was used to form 2.5 mm burr holes through the
skull down to the dura for the placement of optical fibers (see Fig. 6). One DCS source-detector
pair and one DOS/NIRS source-detector pair were used for hemodynamic monitoring. The
positions of these fibers, denoted as (lateral distance from the center of the eye, lateral distance
from midline), are (10 mm, 5 mm), (21 mm, 15 mm), (26 mm, 15 mm), and (37 mm, 5 mm)
for the DCS source, DCS detector, DOS/NIRS source, and DOS/NIRS detector, respectively.
Thus, the source-detector separations for both the DOS/NIRS and DCS pairs are approximately
15 mm.
Upon completion of the surgical preparation, the ventilation of the pig was switched to a
mixture of oxygen and nitrogen (3:7) with no isoflurane. Anesthesia was maintained instead
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with intravenous administration of ketamine (20-60 mg/kg/h). Throughout the rest of the
study, arterial oxygen saturation and end-tidal CO2 were continually monitored with blood
gas samples from the femoral artery and with a capnograph, respectively. The ventilation rate
was initially adjusted to maintain an end-tidal CO2 between 40 and 50 mm Hg.
After inserting ninety-degree bend terminated optical fibers (Fiberoptic Systems, Simi
Valley, CA) in the burr holes, a 5-pound sandbag weight was carefully placed on top of the
fibers to secure them in place. Two 1-mm diameter multi-mode borosilicate fibers (Fiberoptic
Systems) delivered source light to the cerebral tissue, and a third 1-mm diameter multi-mode
fiber received diffusing light from the tissue for DOS/NIRS detection. For DCS detection,
a 4× 1 bundle of 780HP single-mode fibers (Fiberoptic Systems) was used. These fibers
interfaced to a portable custom-built instrument designed for hemodynamic monitoring, which
is described in detail elsewhere [85, 86]. In the DCS measurement, a continuous wave, long
coherence length 785 nm laser (CrystaLaser Inc., Reno, NV) was employed to deliver source
light, and the outputs from an array of 4 high sensitivity avalanche photodiodes (SPCM-AQ4C,
Excelitas, Canada) operating in photon counting mode were connected to a multiple-τ hardware
correlator (Correlator.com, Bridgewater, NJ). In the DOS/NIRS measurement, three lasers (690
nm, 785 nm, 830 nm; OZ Optics, Canada) intensity modulated at 70 MHz were coupled to
an optical switch (DiCon Fiberoptics, Richmond, CA), which sequentially cycled the source
light between the three wavelengths. A heterodyne detection scheme using a photomultiplier
tube (R928, Hamamatsu, Bridgewater, NJ) was employed for DOS/NIRS detection. The data
acquisition was interleaved between DOS/NIRS and DCS to measure blood flow and blood
oxygenation with a sampling rate of 0.15 Hz.
After ten minutes of baseline cerebral hemodynamic monitoring in the pig, the drug
dinitrophenol (DNP, 9mg/kg) was injected intravenously over an hour to dramatically increase
cerebral oxygen metabolism and blood flow [66] (see Fig. 6(B)). The oxygen content in the
ventilated gas was increased as needed to maintain the arterial oxygen saturation in the pig
above 95%. Ketamine was also supplemented as needed with boluses of diazapam (0.1-0.2
mg/kg) to ensure adequate sedation as the oxygen metabolism increased. After two hours of
hemodynamic monitoring, the pig was euthanized with pentobarbital.
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